Successful treatment of paraneoplastic pemphigus and bronchiolitis obliterans associated with follicular lymphoma with obinutuzumab and bendamustine

被引:4
作者
Kuriyama, Kodai [1 ]
Kitamura, Yoshimi [2 ,3 ]
Tsuji, Taisuke [4 ]
Nishikawa, Rina [1 ]
Nagata, Hiroaki [1 ]
Ohshiro, Muneo [1 ]
Sugitani, Mio [1 ]
Hirakawa, Yoshiko [1 ]
Matsumoto, Yosuke [1 ]
Iwai, Toshiki [1 ]
Uchiyama, Hitoji [1 ]
机构
[1] Japanese Red Cross Kyoto Daiichi Hosp, Dept Hematol, Kyoto, Japan
[2] Japanese Red Cross Kyoto Daiichi Hosp, Dept Dermatol, Kyoto, Japan
[3] Kyoto City Hosp, Dept Dermatol, Kyoto, Japan
[4] Japanese Red Cross Kyoto Daiichi Hosp, Dept Resp Med, Kyoto, Japan
关键词
Obinutuzumab; Bendamustine; Follicular lymphoma; Paraneoplastic pemphigus; Bronchiolitis obliterans; MANTLE-CELL LYMPHOMAS; OPEN-LABEL; 1ST-LINE TREATMENT; PLUS RITUXIMAB; MULTICENTER; PREDNISONE; PHASE-3; CHOP; CYCLOPHOSPHAMIDE; CHEMOTHERAPY;
D O I
10.1016/j.currproblcancer.2021.100813
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We herein report the rare case of a 72-year-old female who presented with paraneoplastic pemphigus (PNP) and bronchiolitis obliterans (BO) associated with follicular lymphoma (FL), who was successfully treated with obinutuzumab (GA101; G) and bendamustine (B). The patient had severe erosive stomatitis and bilateral conjunctival hyperemia that persisted for more than 6 months. A huge mass was found in the abdominal cavity, and a biopsy revealed grade 1 FL (stage IV). Based on a lip biopsy result, the pa-tient was diagnosed with PNP associated FL. The patient received bendamustine and obinutuzumab (BG) chemotherapy and FL and PNP responded very well, but BO was additionally associated during the course of BG. BO progressed without exacerbation as BG therapy progressed to a 2 year maintenance therapy with G, and combination of azithromycin, inhaled bronchodilator therapy, and corticosteroid. She was followed up at the outpatient department with no pulmonary function decline or FL and PNP recurrence. Our case suggests that BG could be a promising treatment option for PNP and BO.(c) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页数:6
相关论文
共 25 条
[1]   PARANEOPLASTIC PEMPHIGUS - AN AUTOIMMUNE MUCOCUTANEOUS DISEASE ASSOCIATED WITH NEOPLASIA [J].
ANHALT, GJ ;
KIM, S ;
STANLEY, JR ;
KORMAN, NJ ;
JABS, DA ;
KORY, M ;
IZUMI, H ;
RATRIE, H ;
MUTASIM, D ;
ARISSABDO, L ;
LABIB, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (25) :1729-1735
[2]   The optimal oral biopsy site for diagnosis of mucous membrane pemphigoid and pemphigus vulgaris [J].
Carey, B. ;
Joshi, S. ;
Abdelghani, A. ;
Mee, J. ;
Andiappan, M. ;
Setterfield, J. .
BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (03) :747-753
[3]  
Chan WC, 1997, BLOOD, V89, P3909
[4]  
García-Río F, 1999, NEW ENGL J MED, V341, P848
[5]   Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone:: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group [J].
Hiddemann, W ;
Kneba, M ;
Dreyling, M ;
Schmitz, N ;
Lengfelder, E ;
Schmits, R ;
Reiser, M ;
Metzner, B ;
Harder, H ;
Hegewisch-Becker, S ;
Fischer, T ;
Kropff, M ;
Reis, HE ;
Freund, M ;
Wörmann, B ;
Fuchs, R ;
Planker, M ;
Schimke, J ;
Eimermacher, H ;
Trümper, L ;
Aldaoud, A ;
Parwaresch, R ;
Unterhalt, M .
BLOOD, 2005, 106 (12) :3725-3732
[6]   Paraneoplastic pemphigus occurring after bendamustine and rituximab therapy for relapsed follicular lymphoma [J].
Higo, Takashi ;
Miyagaki, Tomomitsu ;
Nakamura, Fumihiko ;
Shinohara, Akihito ;
Asano, Hiroki ;
Abe, Hiroyuki ;
Senda, Naoyuki ;
Yoshizaki, Ayumi ;
Fukayama, Masashi ;
Kurokawa, Mineo .
ANNALS OF HEMATOLOGY, 2015, 94 (04) :683-685
[7]   Rituximab Monotherapy and Rituximab-Containing Chemotherapy Were Effective for Paraneoplastic Pemphigus Accompanying Follicular Lymphoma, but not for Subsequent Bronchiolitis Obliterans [J].
Hirano, Taichi ;
Higuchi, Yusuke ;
Yuki, Hiromichi ;
Hirata, Shinya ;
Nosaka, Kisato ;
Ishii, Norito ;
Hashimoto, Takashi ;
Mitsuya, Hiroaki ;
Okuno, Yutaka .
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2015, 55 (02) :83-88
[8]   Peri-anal Paraneoplastic Pemphigus Heralding the Relapse of Follicular Lymphoma and Its Successful Management by Rituximab: A Short Correspondence [J].
Jain, Ankur ;
Prakash, Gaurav ;
Nampoothiri, Ram V. ;
De, Dipankar ;
Bal, Amanjit ;
Khadwal, Alka ;
Lad, Deepesh ;
Malhotra, Pankaj ;
Varma, Subhash .
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2016, 32 (04) :519-521
[9]   First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial [J].
Joly, Pascal ;
Maho-Vaillant, Maud ;
Prost-Squarcioni, Catherine ;
Hebert, Vivien ;
Houivet, Estelle ;
Calbo, Sebastien ;
Caillot, Frederique ;
Golinski, Marie Laure ;
Labeille, Bruno ;
Picard-Dahan, Catherine ;
Paul, Carle ;
Richard, Marie-Aleth ;
Bouaziz, Jean David ;
Duvert-Lehembre, Sophie ;
Bernard, Philippe ;
Caux, Frederic ;
Alexandre, Marina ;
Ingen-Housz-Oro, Saskia ;
Vabres, Pierre ;
Delaporte, Emmanuel ;
Quereux, Gaelle ;
Dupuy, Alain ;
Debarbieux, Sebastien ;
Avenel-Audran, Martine ;
D'Incan, Michel ;
Bedane, Christophe ;
Beneton, Nathalie ;
Jullien, Denis ;
Dupin, Nicolas ;
Misery, Laurent ;
Machet, Laurent ;
Beylot-Barry, Marie ;
Dereure, Olivier ;
Sassolas, Bruno ;
Vermeulin, Thomas ;
Benichou, Jacques ;
Musette, Philippe .
LANCET, 2017, 389 (10083) :2031-2040
[10]   Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus [J].
Kikuchi, Taku ;
Mori, Takehiko ;
Shimizu, Takayuki ;
Koda, Yuya ;
Abe, Ryohei ;
Kurihara, Yuichi ;
Funakoshi, Takeru ;
Yamagami, Jun ;
Sato, Hidekazu ;
Tsunoda, Kazuyuki ;
Amagai, Masayuki ;
Okamoto, Shinichiro .
ANNALS OF HEMATOLOGY, 2017, 96 (07) :1221-1222